Keros Therapeutics (KROS) Net Margin (QoQ) (2019 - 2025)

Keros Therapeutics (KROS) Net Margin (QoQ) (2019 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Keros Therapeutics 377.42 Mn 90.02 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 -1.24 Mn
Sep 30, 2025 11,741.00
Jun 30, 2025 -23,923.00
Mar 31, 2025 158,329.00
Dec 31, 2024 1.21 Mn
Mar 31, 2024 -2.38 Mn
Dec 31, 2023 46.49 Mn
Mar 31, 2022 -9,560.00
Dec 31, 2019 3,192.00
Sep 30, 2019 -2,784.00
Jun 30, 2019 1,320.00